The government has increased the cost of certain essential drugs for treating asthma, tuberculosis and others.

Japan: A recent study published in Annals of Allergy, Asthma & Immunology has highlighted the potential of the baseline ...

According to Research by SNS Insider, Nebulizer Market Growth is Driven by Rising Prevalence of Chronic Respiratory Diseases and Technological Advancements.Austin, Oct. 18, 2024 (GLOBE NEWSWIRE) -- ...

Prices of nearly 20 medicines, including those for high blood pressure, cholesterol, and muscle relaxants, are set to rise ...

Inhalers used to treat symptoms of respiratory disease can be potent sources of greenhouse gases. Drugmakers are planning to ...

The medicines for which the prices have been increased are not very expensive to begin with and are not expected to hit ...

Oct. 10, 2024 — The risk of asthma in the child can be reduced by nearly half if the mother engages in active physical exercise at least three times a week during pregnancy, compared to a child ...

The price cap revision will apply to various formulations of benzyl penicillin, atropine, streptomycin, salbutamol, ...

Complex, nationwide analysis included both social and environmental factors and could inform local and national policy.

The National Pharmaceutical Pricing Authority (NPPA) has sanctioned the ceiling price hike for 11 formulations by 50 per cent ...

Patient advocacy group uses report data to push solutions on air pollution, access to medicine, health equity 2024 Asthma ...

In a significant move to address serious respiratory issues in West Virginia, a brand-new sleep and pulmonary clinic has ...